Germany · Delayed Price · Currency is EUR Hannover Rück SE Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw strong earnings, robust reserve build, and solid investment returns, with P&C and Life & Health segments both performing well. Guidance for 2026 is confirmed despite market softening and geopolitical uncertainty.
Fiscal Year 2025
-
Record net income and a 40% dividend increase highlight robust profitability and strong capital generation in 2025. Prudent reserving, resilient balance sheet, and positive outlook for 2026 underpin confidence in continued growth.
-
Net income for the first nine months reached EUR 1.96 billion, prompting an increased full-year target of EUR 2.6 billion. Strong P&C and Life & Health performance, prudent reserving, and realized fixed income losses support future growth, with 2026 guidance set at EUR 2.7 billion.
-
No major strategy changes were announced, with organic growth, efficiency, and client relationships remaining central. The payout ratio rises to 55%, reserve resiliency is high, and NatCat, life & health, and investments are all positioned for continued growth.
-
Net income for H1 2025 reached EUR 1.3 billion, supported by strong underlying profitability, prudent reserving, and positive currency and tax effects. Guidance for 2025 is reaffirmed, with robust growth in both P&C and Life and Health segments and a continued focus on balance sheet strength.
-
Group net income reached EUR 480 million in Q1 2025, with strong underlying profitability and a solvency ratio of 273%. Despite large LA wildfire losses, guidance for at least EUR 2.4 billion net income and robust growth in P&C and Life & Health segments is reaffirmed.
-
Net loss from LA wildfires is estimated at EUR 500–700 million, but strong retrocession and balance sheet strength allow guidance for 2025 to remain unchanged. January renewals saw 7.6% premium growth and a 2.1% decrease in risk-adjusted prices, with stable terms and strong regional performance.
Fiscal Year 2024
-
Net income exceeded EUR 2.3 billion, driven by strong investment and reinsurance results, with a 25% dividend increase proposed. P&C revenue grew 11% and combined ratio was 86.6%, while life & health EBIT rose 7%. 2025 guidance targets EUR 2.4 billion net income.
-
Nine-month net income exceeded EUR 1.8 billion, prompting a full-year guidance increase to EUR 2.3 billion. P&C reinsurance saw strong growth and profitability, while life and health remained stable with positive experience variance. 2025 outlook anticipates further growth and robust returns.
-
Net income rose 21% to EUR 1.16 billion, with strong P&C growth and robust investment returns. Combined ratio improved to 87.8%, and guidance for 2024 is reaffirmed, targeting at least EUR 2.1 billion net income. Confidence in meeting targets is high, though hurricane season remains a risk.